Related Experiment Video
Updated: Jun 22, 2026

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
Published on: March 2, 2014
Inhibition of macrophage activation by the myxoma virus M141 protein (vCD200)
Leiliang Zhang1, Marianne Stanford, Jia Liu
1Department of Molecular Genetics and Microbiology, University of Florida, Gainesville, 32610, USA.
Abstract:
The M141 protein of myxoma virus (MYXV) is a viral CD200 homolog (also called vOX-2) that inhibits macrophage activation in infected rabbits. Here, we show that murine myeloid RAW 264.7 cells became activated when infected with MYXV in which the M141 gene was deleted (vMyx-M141KO) but not with the parental wild-type MYXV. Moreover, transcript and protein levels of tumor necrosis factor and granulocyte colony-stimulating factor were rapidly upregulated in an NF-kappaB-dependent fashion in the RAW 264.7 cells infected with vMyx-M141KO. M141 protein is present in the virion and counteracts this NF-kappaB activation pathway upon infection with the wild-type MYXV. Our data suggest that upregulation of these classic macrophage-related proinflammatory cytokine markers following infection of myeloid cells with the M141-knockout MYXV is mediated via the rapid activation of the cellular NF-kappaB pathway.
Insights
Myxoma virus M141 protein prevents macrophage activation. Deleting the M141 gene in the virus (vMyx-M141KO) activates myeloid cells via the NF-kappaB pathway, increasing inflammatory markers.
Area of Science:
- Virology
- Immunology
- Cell Biology
Background:
- Myxoma virus (MYXV) M141 protein is a viral CD200 homolog (vOX-2).
- M141 inhibits macrophage activation in infected rabbits.
- The role of M141 in myeloid cell activation during MYXV infection is unclear.
Purpose of the Study:
- To investigate the role of MYXV M141 protein in myeloid cell activation.
- To determine the mechanism by which M141 influences inflammatory responses.
Main Methods:
- Infection of murine RAW 264.7 myeloid cells with wild-type MYXV and a M141 gene-deleted mutant (vMyx-M141KO).
- Analysis of cellular activation markers, including tumor necrosis factor and granulocyte colony-stimulating factor.
- Assessment of the NF-kappaB signaling pathway activation.
Main Results:
- RAW 264.7 cells infected with vMyx-M141KO showed activation, unlike cells infected with wild-type MYXV.
- vMyx-M141KO infection led to rapid upregulation of tumor necrosis factor and granulocyte colony-stimulating factor.
- This upregulation was dependent on the NF-kappaB pathway.
- M141 protein, present in wild-type MYXV virions, counteracts NF-kappaB activation.
Conclusions:
- The M141 protein of myxoma virus suppresses myeloid cell activation.
- Deletion of M141 allows for rapid NF-kappaB pathway activation in infected myeloid cells.
- This leads to the upregulation of pro-inflammatory cytokine markers, suggesting a key role for M141 in MYXV immune evasion.
Related Concept Videos
Inhibitors of Virion Maturation and Assembly
Inhibitors Of Virion Release

